Cochrane Systematic Review: Interventions for idiopathic steroid-resistant nephrotic syndrome in children
Hodson EM, Willis NS, Craig JC
Hodson EM, Willis NS, Craig JC
OBJECTIVES: To evaluate the benefits and harms of interventions used to treat idiopathic steroid-resistant nephrotic syndrome (SRNS) in children.
OBJECTIVES: To evaluate the benefits and harms of interventions used to treat idiopathic steroid-resistant nephrotic syndrome (SRNS) in children.
Cochrane Systematic Review: Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease
Sasongko TH, Nagalla S, Ballas SK
Sasongko TH, Nagalla S, Ballas SK
OBJECTIVES: To determine the effectiveness of ACE inhibitor administration in people with sickle cell disease for decreasing intraglomerular pressure, microalbuminuria and proteinuria and to to assess the safety of ACE inhibitors as pertains to their adverse effects.
OBJECTIVES: To determine the effectiveness of ACE inhibitor administration in people with sickle cell disease for decreasing intraglomerular pressure, microalbuminuria and proteinuria and to to assess the safety of ACE inhibitors as pertains to their adverse effects.
Cochrane Systematic Review: Interventions for idiopathic steroid-resistant nephrotic syndrome in children
Hodson EM, Willis NS, Craig JC
Hodson EM, Willis NS, Craig JC
OBJECTIVES: To evaluate the benefits and harms of interventions used to treat idiopathic steroid-resistant nephrotic syndrome (SRNS) in children.
OBJECTIVES: To evaluate the benefits and harms of interventions used to treat idiopathic steroid-resistant nephrotic syndrome (SRNS) in children.
Cochrane Systematic Review: Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease
Sasongko TH, Nagalla S, Ballas SK
Sasongko TH, Nagalla S, Ballas SK
OBJECTIVES: To determine the effectiveness of ACE inhibitor administration in people with sickle cell disease for decreasing intraglomerular pressure, microalbuminuria and proteinuria and to to assess the safety of ACE inhibitors as pertains to their adverse effects.
OBJECTIVES: To determine the effectiveness of ACE inhibitor administration in people with sickle cell disease for decreasing intraglomerular pressure, microalbuminuria and proteinuria and to to assess the safety of ACE inhibitors as pertains to their adverse effects.